Latest Annual Reports News

Seafarms Group Limited has resumed trading on the ASX following the lifting of its suspension, triggered by the lodgement of its annual financial report.

CONNEQT Health has disclosed significant revisions to its 2025 financial results, highlighting increased losses driven by a larger-than-expected fair value write-down on its inHealth investment and a heightened inventory provision.

Aurum Resources Limited has had its trading suspension lifted immediately following the lodgement of its annual financial report, allowing its shares to resume trading on the ASX.

Orion Minerals Ltd has been reinstated to ASX quotation following the release of its 2025 annual report and a new capital raising announcement, ending its trading suspension.

BPH Global Ltd will lift its trading suspension on 2 October 2025 following the lodgement of its annual financial report for the year ended 30 June 2025.

DGR Global Limited will have its trading suspension lifted on 2 October 2025 following the lodgement of its annual report, marking a key step back to market normalcy.

Noble Helium Limited remains suspended from trading as it works through legacy issues delaying its 2025 audited Annual Report. The company is collaborating closely with auditors to resolve outstanding matters and aims to lodge the report promptly.

Cann Group Limited has extended the expiry of its NAB debt facilities by two weeks, providing a brief but vital window to advance its refinancing plans.

FBR Limited’s 2025 Annual Report reveals a substantial $54 million impairment charge that significantly worsens its financial results, pushing total losses to nearly $83 million. The adjustments highlight challenges in capitalised development and asset valuations amid ongoing robotics innovation.

Delorean Corporation has released its audited 2025 Annual Report, revealing key adjustments from its preliminary results including lower revenue, increased tax expenses, and a significant reclassification of borrowings.

Metal Powder Works Limited reports its FY25 annual results, highlighting the accounting treatment of its reverse acquisition and a significant goodwill write-off tied to legacy operations.

Synlait Milk Limited reported an 11.7% rise in revenue to NZD 1.83 billion for the year ending July 2025, yet its net loss deepened sharply to nearly NZD 40 million, prompting a halt on dividends.